Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)-Reference-Cited by-同舟云学术

Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

Published:2014-06 Issue:3 Volume:133 Page:427-432
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Emons Günter,Gorchev Grigor,Sehouli Jalid,Wimberger Pauline,Stähle Anne,Hanker Lars,Hilpert Felix,Sindermann Herbert,Gründker Carsten,Harter Philipp

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference25 articles.

1. American Cancer Society: Cancer Facts and Figs. 2013,2013

2. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer;Lawrie;Cochrane Database Syst Rev,2013

3. Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer;Colombo;J Clin Oncol,2012

4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D‐Cys6‐LHRH vedotin, against ovarian cancer cell lines;Chemical Biology & Drug Design;2024-04

2. Preclinical evaluation of 99m Tc-labeled LHRH as GnRH receptor imaging;2024-01-03

3. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer;International Journal of Molecular Sciences;2023-10-16

4. The role of mycoplasmas as an infectious agent in carcinogenesis;Advances in Molecular Oncology;2023-10-09

5. ‘Renovation of old drugs’ – can peptide drug conjugates lead the post-ADC era?;Australian Journal of Chemistry;2023-06-30